1. Home
  2. TMDX vs GDV Comparison

TMDX vs GDV Comparison

Compare TMDX & GDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • GDV
  • Stock Information
  • Founded
  • TMDX 1998
  • GDV 2003
  • Country
  • TMDX United States
  • GDV United States
  • Employees
  • TMDX N/A
  • GDV N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • GDV Investment Managers
  • Sector
  • TMDX Health Care
  • GDV Finance
  • Exchange
  • TMDX Nasdaq
  • GDV Nasdaq
  • Market Cap
  • TMDX 2.3B
  • GDV 2.0B
  • IPO Year
  • TMDX 2019
  • GDV N/A
  • Fundamental
  • Price
  • TMDX $127.12
  • GDV $24.89
  • Analyst Decision
  • TMDX Buy
  • GDV
  • Analyst Count
  • TMDX 10
  • GDV 0
  • Target Price
  • TMDX $122.89
  • GDV N/A
  • AVG Volume (30 Days)
  • TMDX 1.1M
  • GDV 186.0K
  • Earning Date
  • TMDX 05-08-2025
  • GDV 01-01-0001
  • Dividend Yield
  • TMDX N/A
  • GDV 5.81%
  • EPS Growth
  • TMDX N/A
  • GDV N/A
  • EPS
  • TMDX 1.41
  • GDV N/A
  • Revenue
  • TMDX $488,227,000.00
  • GDV N/A
  • Revenue This Year
  • TMDX $32.58
  • GDV N/A
  • Revenue Next Year
  • TMDX $21.65
  • GDV N/A
  • P/E Ratio
  • TMDX $90.86
  • GDV N/A
  • Revenue Growth
  • TMDX 64.43
  • GDV N/A
  • 52 Week Low
  • TMDX $55.00
  • GDV $18.04
  • 52 Week High
  • TMDX $177.37
  • GDV $23.00
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 76.52
  • GDV 61.88
  • Support Level
  • TMDX $118.79
  • GDV $24.58
  • Resistance Level
  • TMDX $130.48
  • GDV $24.95
  • Average True Range (ATR)
  • TMDX 4.49
  • GDV 0.36
  • MACD
  • TMDX -0.15
  • GDV -0.00
  • Stochastic Oscillator
  • TMDX 83.53
  • GDV 75.49

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About GDV Gabelli Dividend & Income Trust of Beneficial Interest

Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.

Share on Social Networks: